Navigating Reactive Hypoglycemia on Tirzepatide: My Ongoing Journey Without Diabetes

 Tirzepatide has been a powerful force in my personal health transformation. This once-weekly GLP-1/GIP receptor agonist is often hailed for its ability to regulate blood sugar and drive meaningful weight loss. But most of the conversation—and most of the clinical data—focuses on people with Type 2 diabetes.

Let me be clear right from the start:

I do not have diabetes. I do not have Type 2 diabetes.
What I do have is reactive hypoglycemia, a condition where my blood sugar crashes after eating—even when I've had a balanced meal. And for people like me, the experience of taking tirzepatide is nuanced.


A Rare Side Effect, but Very Real for Some of Us

According to studies like SURPASS-4, the incidence of hypoglycemia (defined as <54 mg/dL) on tirzepatide is very low. Only about 1–3% of users not also taking sulfonylureas or insulin experience it. That’s great news—unless you're part of that sliver of the population who does.

For me, 12.5 mg of tirzepatide has triggered more frequent hypoglycemic episodes, even without any other glucose-lowering medications onboard. It’s rare—but it’s real. And it’s happening to me.


Last Fall: A Turning Point

In September, after a few weeks on 12.5 mg, I began crashing. I was seeing blood sugars in the 50s and 60s—sometimes after eating. My doctor saw the trend and insisted I lower my dose.
We aimed for 10 mg, but thanks to a national shortage (yes, despite what Eli Lilly says), I couldn’t find it anywhere locally. So we dropped all the way to 7.5 mg.

That’s when things went sideways:

  • My weight loss progress halted

  • Inflammation returned

  • A compulsive skin-scratching behavior I had previously overcome came roaring back

Tirzepatide had given me back my health. I wasn’t willing to let it go without a fight.


Climbing Back—Carefully

With my provider’s support, we turned to compounded tirzepatide and slowly worked our way back up—first to 10 mg, then finally to 12.5 mg again.

The good news?

  • My progress picked back up.

  • My inflammation calmed.

  • I started feeling like myself again.

The bad news?

  • The low blood sugars returned.


Brunch, Then the Crash

This morning is a perfect example.
We had brunch—protein forward, well balanced. But less than two hours later, my blood sugar tanked into the 60s, then dropped again into the 50s. I caught it quickly thanks to my Freestyle Libre 3 sensor, but it was one of those “here we go again” moments.

Navigating reactive hypoglycemia is perplexing.
I do everything right, and still my glucose dips sharply. It's not predictable. It's not consistent. But it's real—and for me, it seems to be tied to the higher doses of tirzepatide. 



But I’m Still a Champion for This Medicine!!

Let me stress this:

I love tirzepatide.
It has helped me lose over 100 pounds.
It has reversed years of inflammation.
It has restored my quality of life.
It has given me years back.

I will always be a loud voice in support of this medication and the entire GLP-1/GIP class.
But I’ll also be honest about the side effects—especially the ones that aren’t being talked about enough.


What Helps Me

If you’re experiencing blood sugar dips like I am, despite not having diabetes, here are a few things I’ve found helpful:

  • Use a CGM (continuous glucose monitor) like Libre 3 to track patterns in real time

  • Eat smaller, more frequent meals to avoid glucose swings

  • Avoid high glycemic meals on an empty stomach

  • Log meals and symptoms—patterns will emerge

  • Work with a provider who listens and understands this isn’t “one-size-fits-all”


We’re still learning how this class of medicine works in non-diabetic bodies. I’m living proof that while the benefits are profound, side effects—like reactive hypoglycemia—can occur.

I’m not giving up.
I’m adjusting.
And I’m going to figure this out.

Comments

Popular posts from this blog

My Honest Review: Force Factor Hair Growth Accelerator Chews with Lustriva

🗓️ Saturday, June 29-Sun 30th, 2025 Running on Fumes, But Built to Last

🧨 Friday, July 5 – Post-Fourth Reset & Breakthrough Check-In 🎇 END of the 10 month rollercoaster and “STALL"